BioSpace News Archive

Industry-leading pharmaceutical services company, Two Labs, today announced it has acquired Pennside Partners Ltd.,

Rave Mobile Safety (Rave), a trusted partner for safety software protecting millions of individuals, today released key findings from its 2018 survey, Emergency Preparedness and Security Trends in Healthcare after polling hundreds of healthcare safety leaders across the United States.

SCYNEXIS, Inc. (NASDAQ:SCYX), a biotechnology company delivering innovative therapies for difficult-to-treat and often life-threatening infections, today announced the successful completion of an End-of-Phase 2 Meeting with the Food and Drug Administration (FDA) for its lead product candidate, ibrexafungerp (formerly SCY-078), for patients with vulvovaginal candidiasis (VVC).

IDEAYA Biosciences, has entered into an exclusive license agreement with Novartis to develop and commercialize Novartis’ LXS196, a Phase 1 protein kinase C (PKC) inhibitor for the treatment of cancers with GNAQ and GNA11 mutations.

Cardio AIMR Web-based image analysis solution leverages power of deep learning and cloud supercomputing for improved radiologist efficiency and rapid analysis of Cardiac MR images

Medical industry supplier adds a second state-of-the-art Tsugami LaserSwiss machine, which combines laser cutting and CNC Swiss machining in one system

Award-winning Amendola Communications CEO will take a lead role in driving not-for-profit foundation’s marketing, public relations, and social media efforts

Hippocratic Solutions, an outsourced podiatry billing firm, has announced a partnership with iRemedy, a leading ecommerce medical supplies provider. The partnership will allow podiatrists to prescribe, bill for, and dispense advanced wound care supplies through their DME license.

As part of Operation Pangea XI, Health Canada is reminding Canadians of the dangers of buying unauthorized health products online.

MYR Pharma today announced that Food and Drug Administration (FDA) has granted the Breakthrough Therapy designation for its lead compound Myrcludex.